# Metropolis Healthcare Limited (METROPOLIS)

> METROPOLIS closed at ₹545.65 on 30 Oct 2026, trailing P/E 56.1, market cap ₹11,313 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Metropolis Healthcare Limited (NSE: METROPOLIS) closed at ₹545.65 on 30 Oct 2026, +12.6% over one year, against a 52-week range of ₹412.25 – ₹609.05.

In the quarter ended 30 Jun 2026 (consolidated, filed 4 Aug 2026) it reported revenue of ₹450 cr and net profit of ₹57 cr, a 12.6% net margin; revenue grew 16.6% and profit grew 26.9% year on year.

On four consecutive filed quarters its trailing P/E is 56.1; since 13 May 2025 its own P/E has ranged from 51.9 to 79.1 (median 61.0), and today's reading is higher than 10% of those 363 trading days.

From the balance sheet dated 31 Mar 2026: return on equity 15.0%, ROCE 18.6%, debt-to-equity 0.01, Piotroski F-score 7 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 48% of 63 sector peers; PBT margin higher than 48% of 63 sector peers; ROE higher than 56% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹545.65 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -6.4% / +16.8% / +12.6% |
| 52-week low – high | ₹412.25 – ₹609.05 |
| Market capitalisation | ₹11,313 cr |
| Trailing P/E | 56.1 |
| Price / book | 7.48 |
| EV / EBITDA | 25.8 |
| Earnings yield | 1.8% |
| TTM EPS | ₹9.72 |
| TTM net profit | ₹202 cr |
| Quarter revenue | ₹450 cr |
| Quarter net profit | ₹57 cr |
| Net margin | 12.6% |
| Revenue growth (YoY) | +16.6% |
| Profit growth (YoY) | +26.9% |
| Return on equity | 15.0% |
| ROCE | 18.6% |
| Debt / equity | 0.01 |
| Current ratio | 1.40 |
| Free cash flow | ₹307 cr |
| Piotroski F-score | 7 / 9 |
| Average daily turnover (50 days) | ₹10.9 cr |

## Questions

### What is the P/E ratio of Metropolis Healthcare Limited?

Metropolis Healthcare Limited's trailing P/E is 56.1, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 13 May 2025 its P/E has ranged 51.9–79.1.

### What were Metropolis Healthcare Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Metropolis Healthcare Limited reported revenue of ₹450 cr and net profit of ₹57 cr (consolidated), filed with the exchange on 4 Aug 2026.

### What is Metropolis Healthcare Limited's ROE?

Return on equity is 15.0% based on the balance sheet dated 31 Mar 2026.

### Does Metropolis Healthcare Limited have debt?

Debt-to-equity is 0.01 on the balance sheet dated 31 Mar 2026.

### What is METROPOLIS's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, METROPOLIS traded between ₹412.25 and ₹609.05.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/METROPOLIS

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._